Investment Thesis
Catheter Precision exhibits severe financial distress with only $88K in cash reserves against an $8.3M quarterly operating cash burn, creating an imminent liquidity crisis that threatens solvency without immediate capital infusion. While the 95% revenue growth and 92.3% gross margin demonstrate product-market viability, the company's operating losses remain unchanged YoY at -$21.1M, indicating unsustainable fixed cost structure with no credible path to profitability. The 0.10x current ratio indicates the company cannot meet short-term obligations, making this a distressed situation with extreme execution risk.
Strengths
- Revenue growth of 95% YoY shows strong market demand for the surgical device
- Exceptional gross margin of 92.3% demonstrates strong pricing power and product efficiency
- Reasonable debt-to-equity ratio of 0.44x indicates leverage is not structurally problematic
Risks
- Critical liquidity crisis: $88K cash with $8.3M quarterly operating cash burn results in <1 month runway
- Current ratio of 0.10x indicates inability to meet short-term obligations; insolvency risk is acute
- Operating losses unchanged YoY despite 95% revenue growth; no credible path to profitability evident
- Company is pre-cash-flow positive pre-revenue stage with massive unfunded operating requirements
Key Metrics to Watch
- Quarterly cash balance and burn rate trajectory
- Capital raise announcements or financing activities
- Quarterly revenue run-rate and product commercialization progress
- Operating expense reduction initiatives
- Form 8-K filings for going concern warnings or restructuring events
Financial Metrics
Revenue
819.0K
Net Income
-17.2M
EPS (Diluted)
$-25.98
Free Cash Flow
-8.3M
Total Assets
15.9M
Cash
88.0K
Profitability Ratios
Gross Margin
92.3%
Operating Margin
-2,581.6%
Net Margin
-2,098.0%
ROE
-243.6%
ROA
-108.3%
FCF Margin
-1,015.0%
Balance Sheet & Liquidity
Current Ratio
0.10x
Quick Ratio
0.08x
Debt/Equity
0.44x
Debt/Assets
58.1%
Interest Coverage
-528.58x
Long-term Debt
3.1M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-04-18T22:00:21.299259 |
Data as of: 2025-12-31 |
Powered by Claude AI